Regarding the clinical aspects, CD73 overexpression is predictive of a poor prognosis in colorectal, gastric, gallbladder and triple negative breast cancers, as well as in chronic lymphocytic leukemia (for review see [15]). This evidence concerns the gene NT5E and B-cell chronic lymphocytic leukemia.